I think going back to the originally tabled version of the bill was quite effective at strengthening CEPA, but appropriately so, in such a way that it didn't duplicate what was happening elsewhere. What we really want to avoid is duplication or confusion. I think we just finished a government a regulatory road map strategy through the Treasury Board Secretariat that was designed to disentangle some of these, so to re-tangle them would be dangerous.
I think the idea is that when you look at any amendments, you really analyze them: Are they redundant to existing procedures? When we look at plant-based biotechnology, we have a 30-year history of success in Canada and around the world on the benefits it can provide. The robust regulatory program has been working quite well to date.